Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-09

FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for liraglutide from Teva Pharmaceuticals USA, Inc. The action indicates regulatory approval for potential changes to th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

SUPPL AP for LIRAGLUTIDE (LIRAGLUTIDE)